Jian-ning Liu

Title: The Innovations of Jian-ning Liu

Introduction

Jian-ning Liu is a notable inventor based in Brighton, MA (US). He has made significant contributions to the field of diabetes treatment through his innovative research and patented inventions. With a total of 4 patents, Liu's work focuses on developing novel therapeutic approaches for managing diabetes.

Latest Patents

One of Liu's latest patents is the Plasma anti-diabetic NUCB2 peptide (pladin) and its uses. This invention provides a polypeptide known as pladin, which is useful for treating diabetes. The patent outlines a method of treating diabetes by administering nesfatin-1, pladin, or a functional equivalent to a subject. Additionally, it describes a method of treating diabetes by administering plasmin inhibitors. This innovative approach highlights Liu's commitment to advancing diabetes treatment options.

Career Highlights

Throughout his career, Jian-ning Liu has worked with several prominent organizations. He has been associated with Landing Biotech, Inc. and New England Deaconess Hospital Corporation. His work in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Liu has collaborated with notable colleagues, including Victor Gurewich and John Noel Williams. These partnerships have further enriched his research and development efforts in the field of diabetes treatment.

Conclusion

Jian-ning Liu's innovative contributions to diabetes treatment through his patents and collaborations demonstrate his dedication to improving healthcare. His work continues to inspire advancements in medical science and offers hope for better management of diabetes.